AI tools to understand Alzheimer's disease
Artificial Intelligence Strategies for Alzheimer's Disease Research
['FUNDING_U01'] · CEDARS-SINAI MEDICAL CENTER · NIH-11169965
Building AI tools to find hidden patterns in medical and biological data that could help people with Alzheimer's and those at risk.
Quick facts
| Phase | ['FUNDING_U01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | CEDARS-SINAI MEDICAL CENTER (nih funded) |
| Locations | 1 site (LOS ANGELES, UNITED STATES) |
| Trial ID | NIH-11169965 on ClinicalTrials.gov |
What this research studies
We're creating user-friendly AI software (PennAI) that learns from past analyses to make machine learning easier for Alzheimer's research. The team will build new methods to pick out genetic and biological signals across brain scans, blood tests, and other medical records. They will also combine different types of 'omics' data into a single view to reveal links standard methods may miss. The work analyzes large-scale clinical and biological datasets collected from people with and without Alzheimer's.
Who could benefit from this research
Good fit: People with Alzheimer’s disease, mild cognitive impairment, or those at high risk who have contributed clinical or biological data to research studies would be most relevant.
Not a fit: People without research-linked clinical or biological data or those whose memory problems are due to non‑Alzheimer causes may not see direct benefit from this work in the near term.
Why it matters
Potential benefit: If successful, these tools could reveal new biomarkers or disease patterns that speed diagnosis and help guide more targeted treatments for people with Alzheimer's.
How similar studies have performed: Related AI studies have shown promising signals for finding biomarkers and predicting decline in research datasets, but these approaches are still experimental and not yet part of routine care.
Where this research is happening
LOS ANGELES, UNITED STATES
- CEDARS-SINAI MEDICAL CENTER — LOS ANGELES, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: MOORE, JASON H. — CEDARS-SINAI MEDICAL CENTER
- Study coordinator: MOORE, JASON H.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Alzheimer disease dementia, Alzheimer syndrome, Alzheimer's Disease, Alzheimer's disease biological marker